CTNM/ 09/14/2026 · 4:37 PM Contineum’s J&J-Partnered Depression Drug Misses Phase 2 Goal Contineum said its J&J-partnered drug PIPE-307 missed the Phase 2 primary goal of improving MADRS scores at Day 5 versus placebo.
